Skip to content

Up-positioning of the Testes as Supportive Therapy in Patients With Acute Orchitis

Up-positioning of the Testes as Supportive Therapy in Patients With Acute Orchitis - a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02665182
Acronym
EleScro
Enrollment
70
Registered
2016-01-27
Start date
2012-07-31
Completion date
2021-01-31
Last updated
2018-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orchitis, Testicular Diseases

Keywords

orchitis, testicular diseases

Brief summary

This is a single-blinded RCT evaluating the value of up-positioning of the testes as supportive therapy in patients receiving antimicrobial treatment due to acute bacterial orchitis.

Interventions

BEHAVIORALUp-positioning of the testes

Patients in the experimental arm are asked to elevate their testes during the treatment.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute orchitis confirmed clinically and in scrotal ultrasound * age \>=18 yrs

Exclusion criteria

* previous treatment of orchitis, * need for exploration of the scrotum, * need for hospitalization, * physical and mental status not allowing for up-positioning of the testes during treatment

Design outcomes

Primary

MeasureTime frame
Time to alleviation of symptoms10 days
Time to clinical resolution of local symptoms10 days

Secondary

MeasureTime frame
Testicular erythema10 days
Scrotal pain intensity10 days
Quality of life10 days
Testicular pain10 days
Heart rate10 days
Duration of up-positioning of testes per day10 days
Body temperature10 days
Testicular swelling10 days

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026